Abstracted Scientific Content

Published in:
Volume 6 / Year 2017 / Issue 4

A comparison of European and US generic drug markets

Author(s):
Page: 190-2

Submitted: 19 June 2017; Revised: 5 September 2017; Accepted: 6 September 2017; Published online first: 19 September 2017 Introduction Comparative research on the European and US generic drug markets based on 2013 IMS data… Read More »

Randomized non-inferiority trial fails to find inferiority switching from infliximab originator to CT-P13 biosimilar

Author(s):
Page: 188-9

Submitted: 17 November 2017; Revised: 20 November 2017; Accepted: 22 November 2017; Published online first: 5 December 2017 The tumour necrosis factor (TNF) inhibitor infliximab is known to significantly improve the treatment of… Read More »

Go Back Print